Atrial septal defect market to reach $6.26 billion by 2030

The global atrial septal defect market is projected to grow from $4.81 billion in 2026 to $6.26 billion by 2030, driven by better detection, broader access to minimally invasive procedures and rising congenital heart defect cases. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through the forecast period.

Why it matters: - The atrial septal defect market is expanding as more patients are diagnosed earlier and more treatment options become available. - Growth in congenital heart defect cases is keeping demand high for device-based closures, surgery and long-term follow-up care. - The market’s forecast signals continued investment in pediatric cardiology, imaging and minimally invasive cardiac procedures.

What happened: - The Business Research Company released its Global Market Report 2026 for the atrial septal defect market, covering market size, trends and forecasts for 2026-2035. - The market rose from $4.46 billion in 2025 to an expected $4.81 billion in 2026, equal to a 7.8% CAGR. - The market is projected to reach $6.26 billion by 2030, with growth continuing at a 6.8% CAGR over that period. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period.

The details: - Better detection methods for congenital heart defects helped lift near-term growth. - Wider availability of surgical interventions supported market expansion. - Growth in pediatric cardiology services added to demand. - Greater expertise in device-based closures also boosted adoption. - Advanced diagnostic imaging tools improved diagnosis and treatment planning. - Hybrid closure techniques are becoming more common. - Early adult interventions are gaining more attention. - Minimally invasive cardiac surgery continues to improve. - Occluder device design is still evolving. - Demand is rising for long-term follow-up care after treatment. - The report highlights increased use of transcatheter closure devices. - Less invasive repair methods are becoming a stronger preference. - Cardiac imaging use is expanding. - Screening programs for children and adults are growing. - The report covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The report also adds market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and future trend analysis. - The report includes a free sample download: Download the sample report. - The full report is available here: View the full market report.

Between the lines: - The market’s growth is being driven by a mix of medical need and technology adoption, not by one single factor. - The shift toward transcatheter and other less invasive approaches suggests continued pressure to reduce recovery time and improve patient outcomes. - North America’s lead points to stronger access and awareness, while Asia-Pacific’s growth outlook suggests rising unmet need and healthcare system expansion.

What's next: - The market is expected to keep growing through 2030 as early detection and treatment access improve. - Device innovation and imaging advances are likely to remain key competitive factors. - Broader screening and long-term care needs should continue to support demand across pediatric and adult patient groups. - The Business Research Company lists contact details for expert inquiries and media follow-up in the release.